MCI BPO Announces the Acquisition of Guthy-Renker's Contact
MIAMI BEACH, Fla., Feb. 20, 2023 (GLOBE NEWSWIRE) -- MCI is proud to announce the acquisition of OceanX LLC, a wholly owned subsidiary of Guthy-Renker...
Stay updated with breaking news from Mci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MIAMI BEACH, Fla., Feb. 20, 2023 (GLOBE NEWSWIRE) -- MCI is proud to announce the acquisition of OceanX LLC, a wholly owned subsidiary of Guthy-Renker...
A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.
Clinicians should consider detailed testing of patients with cognitive complaints for accurate diagnosis and management.
Isothiazolinone allergy prevalence is down in Europe, but it is up in North America, likely because of regulatory differences, researchers report.
A polypill that targets vascular risk factors can help slow functional but not cognitive decline compared with placebo in older relatively healthy adults, new research suggests.